Literature DB >> 25523509

An overview of regular dialysis treatment in Japan (as of 31 December 2012).

Shigeru Nakai1, Norio Hanafusa, Ikuto Masakane, Masatomo Taniguchi, Takayuki Hamano, Tetsuo Shoji, Takeshi Hasegawa, Noritomo Itami, Kunihiro Yamagata, Toshio Shinoda, Junichiro James Kazama, Yuzo Watanabe, Takashi Shigematsu, Seiji Marubayashi, Osamu Morita, Atsushi Wada, Seiji Hashimoto, Kazuyuki Suzuki, Hidetomo Nakamoto, Naoki Kimata, Kenji Wakai, Naohiko Fujii, Satoshi Ogata, Kenji Tsuchida, Hiroshi Nishi, Kunitoshi Iseki, Yoshiharu Tsubakihara.   

Abstract

A nationwide statistical survey of 4279 dialysis facilities was conducted at the end of 2012, among which 4238 responded (99.0%). The number of new dialysis patients was 38055 in 2012. Since 2008, the number of new dialysis patients has remained almost the same without any marked increase or decrease. The number of dialysis patients who died in 2012 was 30710; a slight decrease from 2011 (30743). The dialysis patient population has been growing every year in Japan; it was 310007 at the end of 2012, which exceeded 310000 for the first time. The number of dialysis patients per million at the end of 2012 was 2431.2. The crude death rate of dialysis patients in 2012 was 10.0%, a slight decrease from that in 2011 (10.2%). The mean age of new dialysis patients was 68.5 years and the mean age of the entire dialysis patient population was 66.9 years. The most common primary cause of renal failure among new dialysis patients was diabetic nephropathy (44.2%). The actual number of new dialysis patients with diabetic nephropathy has been approximately 16000 for the last few years. Diabetic nephropathy was also the most common primary disease among the entire dialysis patient population (37.1%), followed by chronic glomerulonephritis (33.6%). The percentage of dialysis patients with diabetic nephropathy has been continuously increasing, whereas not only the percentage but also the actual number of dialysis patients with chronic glomerulonephritis has decreased. The number of patients who underwent hemodiafiltration (HDF) at the end of 2012 was 21725, a marked increase from that in 2011 (14115). In particular, the number of patients who underwent on-line HDF increased threefold from 4890 in 2011 to 14069 in 2012. From the results of the facility survey, the number of patients who underwent peritoneal dialysis (PD) was 9514 and that of patients who did not undergo PD despite having a PD catheter in the abdominal cavity was 347. From the results of the patient survey, among the PD patients, 1932 also underwent another dialysis method using extracorporeal circulation, such as hemodialysis (HD) and HDF. The number of patients who underwent HD at home in 2012 was 393, a marked increase from that in 2011 (327).
© 2014 Japanese Society for Dialysis Therapy. Reproduced with permission.

Entities:  

Keywords:  Chronic kidney disease-mineral and bone disorder; Dialysis patient population; Erythropoiesis-stimulating agent; On-line hemodiafiltration; Survival rate

Mesh:

Year:  2014        PMID: 25523509     DOI: 10.1111/1744-9987.12281

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  40 in total

1.  Development and validation of a short-version checklist for patients undergoing hemodialysis based on the International Classification of Functioning, Disability and Health.

Authors:  Hideyo Tsutsui; Takayoshi Ohkubo; Yoshinari Tsuruta; Sawako Kato; Yoshinari Yasuda; Yoshiharu Oshida
Journal:  Clin Exp Nephrol       Date:  2014-12-28       Impact factor: 2.801

2.  Assessment of ocular microcirculation in patients with end-stage kidney disease.

Authors:  Tetsushi Arimura; Tomoaki Shiba; Mao Takahashi; Shun Kumashiro; Hironori Osamura; Tadashi Matsumoto; Ken Sakai; Yuichi Hori
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-09-10       Impact factor: 3.117

3.  Early response to erythropoiesis-stimulating agents in non-dialysis chronic kidney disease patients.

Authors:  Michio Kuwahara; Youhei Arai; Eriko Takehara; Yasunori Sasaki; Tomoharu Yoshimine; Keita Kusaka; Satomi Shikuma; Wataru Akita; Shinichi Uchida
Journal:  Clin Exp Nephrol       Date:  2015-10-28       Impact factor: 2.801

4.  Quantification of autonomic nervous activity by heart rate variability and approximate entropy in high ultrafiltration rate during hemodialysis.

Authors:  Yoshihiro Tsuji; Naoki Suzuki; Yasumasa Hitomi; Toshiko Yoshida; Yuko Mizuno-Matsumoto
Journal:  Clin Exp Nephrol       Date:  2016-08-01       Impact factor: 2.801

5.  A clinical staging score to measure the severity of dialysis-related amyloidosis.

Authors:  Junichi Hoshino; Masahiro Kawada; Aya Imafuku; Koki Mise; Keiichi Sumida; Rikako Hiramatsu; Eiko Hasegawa; Noriko Hayami; Masayuki Yamanouchi; Tatsuya Suwabe; Naoki Sawa; Yoshifumi Ubara; Kenmei Takaichi
Journal:  Clin Exp Nephrol       Date:  2016-06-23       Impact factor: 2.801

6.  Prognostic factors for mortality in middle-aged and older hemodialysis patients: a 5-year observational study.

Authors:  Kojiro Nagai; Motokazu Matsuura; Kenji Tsuchida; Hiro-Omi Kanayama; Toshio Doi; Jun Minakuchi
Journal:  J Artif Organs       Date:  2017-09-16       Impact factor: 1.731

7.  Inequalities in access to pediatric ESRD care: a global health challenge.

Authors:  Jérôme Harambat; Pepe Mfutu Ekulu
Journal:  Pediatr Nephrol       Date:  2015-12-01       Impact factor: 3.714

8.  Switching from subcutaneous insulin injection to oral vildagliptin administration in hemodialysis patients with type 2 diabetes: a pilot study.

Authors:  Naoshi Yoshida; Tetsuya Babazono; Ko Hanai; Yasuko Uchigata
Journal:  Int Urol Nephrol       Date:  2016-05-18       Impact factor: 2.370

9.  What Is Known and Unknown About Twice-Weekly Hemodialysis.

Authors:  Yoshitsugu Obi; Rieko Eriguchi; Shuo-Ming Ou; Connie M Rhee; Kamyar Kalantar-Zadeh
Journal:  Blood Purif       Date:  2015-11-17       Impact factor: 2.614

10.  Clinical characteristics and outcomes of dialysis patients with atrial fibrillation: the Fushimi AF Registry.

Authors:  Yugo Yamashita; Daisuke Takagi; Yasuhiro Hamatani; Moritake Iguchi; Nobutoyo Masunaga; Masahiro Esato; Yeong-Hwa Chun; Hitoshi Itoh; Masato Nishimura; Hiromichi Wada; Koji Hasegawa; Hisashi Ogawa; Mitsuru Abe; Masaharu Akao
Journal:  Heart Vessels       Date:  2016-03-14       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.